- Home
- KALV vs ASPI Comparison
KALV vs ASPI Comparison
Compare KALV & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- ASPI
- Stock Information
- Founded
- KALV N/A
- ASPI 2021
- Country
- KALV United States
- ASPI United States
- Employees
- KALV N/A
- ASPI N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- ASPI Major Chemicals
- Sector
- KALV Health Care
- ASPI Industrials
- Exchange
- KALV Nasdaq
- ASPI Nasdaq
- Market Cap
- KALV 563.1M
- ASPI 298.8M
- IPO Year
- KALV N/A
- ASPI 2022
- Fundamental
- Price
- KALV $11.45
- ASPI $4.35
- Analyst Decision
- KALV Strong Buy
- ASPI Strong Buy
- Analyst Count
- KALV 8
- ASPI 2
- Target Price
- KALV $24.83
- ASPI $4.50
- AVG Volume (30 Days)
- KALV 567.9K
- ASPI 1.2M
- Earning Date
- KALV 03-12-2025
- ASPI 05-14-2025
- Dividend Yield
- KALV N/A
- ASPI N/A
- EPS Growth
- KALV N/A
- ASPI N/A
- EPS
- KALV N/A
- ASPI N/A
- Revenue
- KALV N/A
- ASPI $3,383,374.00
- Revenue This Year
- KALV N/A
- ASPI $865.76
- Revenue Next Year
- KALV N/A
- ASPI $700.00
- P/E Ratio
- KALV N/A
- ASPI N/A
- Revenue Growth
- KALV N/A
- ASPI N/A
- 52 Week Low
- KALV $7.30
- ASPI $1.86
- 52 Week High
- KALV $15.50
- ASPI $9.33
- Technical
- Relative Strength Index (RSI)
- KALV 47.44
- ASPI 45.33
- Support Level
- KALV $11.83
- ASPI $4.17
- Resistance Level
- KALV $12.50
- ASPI $4.81
- Average True Range (ATR)
- KALV 0.58
- ASPI 0.36
- MACD
- KALV -0.16
- ASPI 0.05
- Stochastic Oscillator
- KALV 19.46
- ASPI 27.23
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.